Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Wellnex Life Ltd ( (AU:WNX) ) has issued an announcement.
Wellnex Life reported a sharp improvement in operating cash flow in the December 2025 quarter, with net operating cash outflow reduced to $0.16 million from $2.98 million in the prior quarter, supported by a 31.5% quarter-on-quarter rise in total revenue to $7.1 million and stronger customer cash receipts of $5.1 million. The result was driven by a 1000% surge in IP licensing revenue to $3.3 million and ongoing strength in the Pain Away brand, partially offset by a 25.5% decline in branded product sales following a deliberate move to consolidate and deprioritise non-core assets; the company ended the quarter with $0.98 million in cash and $2.01 million in undrawn facilities and reaffirmed its focus on turnaround efforts, better cash conversion, margin enhancement and cost reduction.
The most recent analyst rating on (AU:WNX) stock is a Hold with a A$0.16 price target. To see the full list of analyst forecasts on Wellnex Life Ltd stock, see the AU:WNX Stock Forecast page.
More about Wellnex Life Ltd
Wellnex Life Limited (ASX/AIM: WNX) operates in the health and wellness sector, with a portfolio of consumer brands including its core Pain Away brand. The company focuses on branded products and intellectual property licensing, targeting improved profitability through consolidation of non-core assets and a disciplined balance-sheet strategy.
Average Trading Volume: 69,564
Technical Sentiment Signal: Sell
Current Market Cap: A$11.54M
For an in-depth examination of WNX stock, go to TipRanks’ Overview page.